Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Change in Account Payables (2016 - 2026)

Champions Oncology (CSBR) has 16 years of Change in Account Payables data on record, last reported at $1.3 million in Q4 2025.

  • For Q4 2025, Change in Account Payables rose 443.19% year-over-year to $1.3 million; the TTM value through Oct 2025 reached $920000.0, up 189.31%, while the annual FY2025 figure was -$1.7 million, 476.13% down from the prior year.
  • Change in Account Payables reached $1.3 million in Q4 2025 per CSBR's latest filing, up from $411000.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $2.1 million in Q4 2022 and bottomed at -$2.0 million in Q1 2021.
  • Average Change in Account Payables over 5 years is $103150.0, with a median of $141500.0 recorded in 2021.
  • The widest YoY moves for Change in Account Payables: up 1443.28% in 2022, down 635.57% in 2022.
  • A 5-year view of Change in Account Payables shows it stood at $134000.0 in 2021, then skyrocketed by 1443.28% to $2.1 million in 2022, then plummeted by 159.19% to -$1.2 million in 2023, then soared by 68.79% to -$382000.0 in 2024, then surged by 443.19% to $1.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Account Payables were $1.3 million in Q4 2025, $411000.0 in Q3 2025, and -$614000.0 in Q2 2025.